Literature DB >> 24290334

Impact of educational interventions on adverse drug events reporting.

Caroline Pagotto1, Fabiana Varallo, Patrícia Mastroianni.   

Abstract

INTRODUCTION: Spontaneous adverse drug events (ADE) reporting is the main source of data for assessing the risk/benefit of drugs available in the pharmaceutical market. However, its major limitation is underreporting, which hinders and delays the signal detection by Pharmacovigilance (PhV).
OBJECTIVES: To identify the techniques of educational intervention (EI) for promotion of PhV by health professionals and to assess their impact.
METHODS: A systematic review was performed in the PUBMED, PAHO, LILACS and EMBASE databases, from November/2011 to January/2012, updated in March/2013. The strategy search included the use of health descriptors and a manual search in the references cited by selected papers.
RESULTS: 101 articles were identified, of which 16 met the inclusion criteria. Most of these studies (10) were conducted in European hospitals and physicians were the health professionals subjected to most EI (12), these studies lasted from one month to two years. EI with multifaceted techniques raised the absolute number, the rate of reporting related to adverse drug reactions (ADR), technical defects of health technologies, and also promoted an improvement in the quality of reports, since there was increased reporting of ADR classified as serious, unexpected, related to new drugs and with high degree of causality.
CONCLUSION: Multifaceted educational interventions for multidisciplinary health teams working at all healthcare levels, with sufficient duration to reach all professionals who act in the institution, including issues related to medication errors and therapeutic ineffectiveness, must be validated, with the aim of standardizing the Good Practice of PhV and improve drug safety indicators.

Entities:  

Mesh:

Year:  2013        PMID: 24290334     DOI: 10.1017/S0266462313000457

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  23 in total

1.  Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; María Piñeiro-Lamas; Adolfo Figueiras
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

2.  Effect of Educational Interventions on Adverse Drug Reaction Reporting in a Cancer Institute in Japan: A Questionnaire Study.

Authors:  Masami Tsuchiya; Akihisa Esashi; Taku Obara; Kyoko Inooka; Nariyasu Mano; Chizuko Takamura
Journal:  Hosp Pharm       Date:  2018-04-13

3.  Pharmacovigilance in developing countries (part II): a path forward.

Authors:  Shaimaa Elshafie; Anne Marie Roberti; Iman Zaghloul
Journal:  Int J Clin Pharm       Date:  2018-08

4.  Teaching Pharmacovigilance to Undergraduate Students: Our Experience in Poor-Resource Setting.

Authors:  Mohammed Alshakka; Wafa Badullah; Abdullah Al-Dhuraibi; Sara Alshagga; Mohamed Izham Mohamed Ibrahim
Journal:  J Pharm Bioallied Sci       Date:  2022-05-19

5.  Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  Int J Clin Pharm       Date:  2014-10-07

6.  Medical students as junior adverse drug event managers facilitating reporting of ADRs.

Authors:  Michael O Reumerman; Jelle Tichelaar; Milan C Richir; Michiel A van Agtmael
Journal:  Br J Clin Pharmacol       Date:  2021-05-26       Impact factor: 3.716

7.  A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals.

Authors:  Stella Stergiopoulos; Carrie A Brown; Thomas Felix; Gustavo Grampp; Kenneth A Getz
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

8.  Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff.

Authors:  Fabiana Rossi Varallo; Cleopatra S Planeta; Patricia de Carvalho Mastroianni
Journal:  Clinics (Sao Paulo)       Date:  2017-01-01       Impact factor: 2.365

Review 9.  A narrative review of evidence to guide deprescribing among older adults.

Authors:  Kenya Ie; Shuichi Aoshima; Taku Yabuki; Steven M Albert
Journal:  J Gen Fam Med       Date:  2021-05-28

10.  Promoting adverse drug reaction reporting: comparison of different approaches.

Authors:  Inês Ribeiro-Vaz; Cristina Costa Santos; Ricardo Cruz-Correia
Journal:  Rev Saude Publica       Date:  2016-05-03       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.